Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Xuebijing Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
2 trials -
Xuesaitong Soft Capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease
2 trials -
Xueshuanxinmaining tablet
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Coronary Heart Disease
1 trial -
Yiqitongluo granule
The First People's Hospital of Lianyungang
Stroke
1 trial -
Z-Brace interbody fusion device
Hospital Authority, Hong Kong
Cervical Disc Degeneration
1 trial -
Zavicefta, Ceftazidime-Avibactam
Pfizer
Hospital-Acquired Pneumonia
1 trial -
Zhenyuan capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Stable Coronary Heart Disease
1 trial -
Zushima plaster with high dose
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Osteoarthritis
1 trial -
a control group
The First People's Hospital of Lianyungang
Disorder of Stomach Function and Feeding Problems in Newborn
1 trial -
albumin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sepsis
1 trial -
aspirin 100mg/d therapy
The First People's Hospital of Lianyungang
Coronary Atherosclerosis
1 trial -
aspirin and clopidogrel
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
berberine hydrochloride
The First People's Hospital of Lianyungang
Hypertension
1 trial -
biologics treatment
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Psoriasis
1 trial -
budesonide
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Respiratory Distress Syndrome
1 trial -
budesonide/formoterol
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cough Variant Asthma
1 trial -
butylphthalide(NBP)
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
conbercept
Hospital Authority, Hong Kong
Polypoidal Choroidal Vasculopathy
1 trial -
conventional dose epinephrine
Hospital Authority, Hong Kong
Croup
1 trial -
crizotinib
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Systemic Anaplastic Large-Cell Lymphoma
1 trial -
dapagliflozin
The First People's Hospital of Lianyungang
Diabetic Kidney Disease
1 trial -
dexmedetomidine
The First People's Hospital of Lianyungang
Postoperative Cognitive Dysfunction
1 trial -
dexmedetomidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sleep Quality of Patients Undergoing TURP
1 trial -
dexmedetomidine
The First People's Hospital of Lianyungang
Aged
3 trials
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources